154 related articles for article (PubMed ID: 12942091)
1. Transplantation for chronic myelogenous leukemia: yes, no, maybe so. . . An Oregon perspective.
Maziarz RT; Mauro MJ
Bone Marrow Transplant; 2003 Sep; 32(5):459-69. PubMed ID: 12942091
[TBL] [Abstract][Full Text] [Related]
2. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.
Simon W; Segel GB; Lichtman MA
Blood Cells Mol Dis; 2006; 37(2):116-24; discussion 125-7. PubMed ID: 16904348
[TBL] [Abstract][Full Text] [Related]
3. Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?
Pulsipher MA
Pediatr Blood Cancer; 2004 Oct; 43(5):523-33. PubMed ID: 15382266
[TBL] [Abstract][Full Text] [Related]
4. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
DeAngelo DJ; Hochberg EP; Alyea EP; Longtine J; Lee S; Galinsky I; Parekkedon B; Ritz J; Antin JH; Stone RM; Soiffer RJ
Clin Cancer Res; 2004 Aug; 10(15):5065-71. PubMed ID: 15297408
[TBL] [Abstract][Full Text] [Related]
5. [Stem cell transplantation in the imatinib era].
Masszi T
Orv Hetil; 2005 May; 146(18 Suppl 1):900-4. PubMed ID: 15921302
[TBL] [Abstract][Full Text] [Related]
6. A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation.
Weisser M; Tischer J; Schnittger S; Schoch C; Ledderose G; Kolb HJ
Haematologica; 2006 May; 91(5):663-6. PubMed ID: 16627251
[TBL] [Abstract][Full Text] [Related]
7. Who with chronic myelogenous leukemia to transplant in the era of tyrosine kinase inhibitors?
Maziarz RT
Curr Opin Hematol; 2008 Mar; 15(2):127-33. PubMed ID: 18300759
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation for chronic myeloid leukemia-status in 2007.
Goldman J
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S11-S13. PubMed ID: 18724281
[TBL] [Abstract][Full Text] [Related]
9. Clinical decisions for chronic myeloid leukemia in the imatinib era.
Goldman JM; Marin D; Olavarria E; Apperley JF
Semin Hematol; 2003 Apr; 40(2 Suppl 2):98-103; discussion 104-13. PubMed ID: 12783383
[TBL] [Abstract][Full Text] [Related]
10. Resistance to pretransplant imatinib therapy may adversely affect the outcome of allogeneic stem cell transplantation in CML.
Weisser M; Schmid C; Schoch C; Hiddemann W; Kolb HJ
Bone Marrow Transplant; 2005 Dec; 36(11):1017-8. PubMed ID: 16184176
[No Abstract] [Full Text] [Related]
11. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia.
Radich JP; Olavarria E; Apperley JF
Hematol Oncol Clin North Am; 2004 Jun; 18(3):685-702, x. PubMed ID: 15271400
[TBL] [Abstract][Full Text] [Related]
12. Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis.
Palandri F; Amabile M; Rosti G; Bandini G; Benedetti F; Usala E; Angelucci E; Tiribelli M; Fanin R; Martinelli G; Baccarani M
Bone Marrow Transplant; 2007 Feb; 39(3):189-91. PubMed ID: 17211436
[No Abstract] [Full Text] [Related]
13. [An advance in the treatment of CML].
Ohnishi K
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2185-90. PubMed ID: 18079618
[TBL] [Abstract][Full Text] [Related]
14. First-Line management of CML: a state of the art review.
Hochhaus A
J Natl Compr Canc Netw; 2008 Mar; 6 Suppl 2():S1-S10. PubMed ID: 18397676
[TBL] [Abstract][Full Text] [Related]
15. [Imatinib therapy for patients with chronic myelogenous leukemia].
Usui N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):297-303. PubMed ID: 15791812
[TBL] [Abstract][Full Text] [Related]
16. Optimal initial therapy for patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Atallah E; Cortes J
Curr Opin Hematol; 2007 Mar; 14(2):138-44. PubMed ID: 17255791
[TBL] [Abstract][Full Text] [Related]
17. The treatment of pediatric Philadelphia positive (Ph+) leukemias in the imatinib era.
Burke MJ; Willert J; Desai S; Kadota R
Pediatr Blood Cancer; 2009 Dec; 53(6):992-5. PubMed ID: 19621426
[TBL] [Abstract][Full Text] [Related]
18. The role of interferon-alpha in the treatment of chronic myeloid leukemia.
Kujawski LA; Talpaz M
Cytokine Growth Factor Rev; 2007; 18(5-6):459-71. PubMed ID: 17703986
[TBL] [Abstract][Full Text] [Related]
19. [Chronic myelogenous leukaemia: recent progress in biology and therapeutic strategies].
Turhan AG
Bull Cancer; 2005 Jan; 92(1):75-82. PubMed ID: 15689327
[TBL] [Abstract][Full Text] [Related]
20. Severe epidermal necrolysis after treatment with imatinib and consecutive allogeneic hematopoietic stem cell transplantation.
Schaich M; Schäkel K; Illmer T; Ehninger G; Bornhäuser M
Ann Hematol; 2003 May; 82(5):303-4. PubMed ID: 12707720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
